Perry P A, Webb R C
Department of Physiology, University of Michigan Medical School, Ann Arbor.
Hypertension. 1991 May;17(5):603-11. doi: 10.1161/01.hyp.17.5.603.
The present study characterizes cellular calcium stores that are sensitive to norepinephrine and caffeine in arteries from deoxycorticosterone acetate hypertensive rats. Mesenteric arteries from normotensive and hypertensive rats were excised and cut into helical strips for isometric force recording. In calcium-free solution, phasic contractile responses to norepinephrine (5.9 x 10(-9) to 5.9 x 10(-6) M), but not caffeine (0.3-30 mM), were greater in hypertensive arteries. D-600, a calcium channel blocker, or removal of the endothelium did not alter phasic contractions to norepinephrine or caffeine. In contrast, contractions to both norepinephrine and caffeine were inhibited by ryanodine, a drug that depletes calcium from intracellular stores. An inhibitor of phospholipase C (2-nitro-4-carboxyphenyl N,N-diphenylcarbamate) attenuated contractions to norepinephrine but not those to caffeine. The augmented response to norepinephrine in hypertensive rats did not occur early after implantation of the mineralocorticoid, suggesting that this vascular change may not play a role in the development of high blood pressure in this experimental model. The augmented response to norepinephrine was reduced in mineralocorticoid-treated rats maintained on a low sodium diet, and these rats had blood pressures in the normotensive range. Because contractile responses to caffeine were not enhanced in arteries from hypertensive rats, we conclude that the cellular store for calcium is not enlarged compared with that in normotensive arteries. In contrast, the mobilization of calcium from cellular stores by norepinephrine is augmented in mineralocorticoid hypertension. This augmented response may be linked to altered phospholipase C activity and thus to an augmented action of inositol trisphosphate that releases calcium from intracellular sites.
本研究对醋酸脱氧皮质酮高血压大鼠动脉中对去甲肾上腺素和咖啡因敏感的细胞钙库进行了表征。切除正常血压和高血压大鼠的肠系膜动脉,并切成螺旋条用于等长张力记录。在无钙溶液中,高血压动脉对去甲肾上腺素(5.9×10⁻⁹至5.9×10⁻⁶M)的阶段性收缩反应增强,但对咖啡因(0.3 - 30 mM)的反应未增强。钙通道阻滞剂D - 600或去除内皮均未改变对去甲肾上腺素或咖啡因的阶段性收缩。相反,ryanodine(一种从细胞内储存中耗尽钙的药物)抑制了对去甲肾上腺素和咖啡因的收缩。磷脂酶C抑制剂(2 - 硝基 - 4 - 羧基苯基N,N - 二苯基氨基甲酸盐)减弱了对去甲肾上腺素的收缩,但不影响对咖啡因的收缩。高血压大鼠对去甲肾上腺素的增强反应在植入盐皮质激素后早期并未出现,表明这种血管变化可能在该实验模型的高血压发展中不起作用。在低钠饮食的盐皮质激素处理大鼠中,对去甲肾上腺素的增强反应降低,且这些大鼠的血压处于正常血压范围。由于高血压大鼠动脉对咖啡因的收缩反应未增强,我们得出结论,与正常血压动脉相比,细胞钙储存未扩大。相反,在盐皮质激素性高血压中,去甲肾上腺素从细胞储存中动员钙的能力增强。这种增强反应可能与磷脂酶C活性改变有关,进而与肌醇三磷酸从细胞内位点释放钙的增强作用有关。